Studies of type IV collagenase regulation by hypoxia

Cancer Letters

Volumn 124, Issue 2, 1998, Pages 127-133

  Himelstein, Bruce P ^a   Koch, Cameron J ^b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Hypoxia; Metalloproteinases; Metastasis

Indexed keywords

COLLAGENASE; GELATINASE A; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; RNA; TRANSCRIPTION FACTOR AP 1;

ARTICLE; CONSENSUS SEQUENCE; CONTROLLED STUDY; ENZYME REGULATION; HELA CELL; HUMAN; HUMAN CELL; HYPOXIA; METASTASIS; PRIORITY JOURNAL; PROMOTER REGION; RHABDOMYOSARCOMA; SOLID TUMOR; TRANSACTIVATION;

EID: 0032570760     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(97)00463-1     Document Type: Article

References (32)

1. Hockel M., Schlenger K., Aral B., Mitze M., Schaffer U., Vaupel P. Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix. Cancer Res. 56:1996;4509-4515.
2. Brizel D., Scully S., Harrelson J.et al. Tumor oxygenation predicts for the likelihood of distant metastases in human soft tissue sarcoma. Cancer Res. 56:1996;941-943.
3. Librach C., Werb Z., Fitzgerald M.L.et al. 92-kD type IV collagenase mediates invasion of human cytotrophoblasts. J. Cell Biol. 113:1991;437-449.
4. Bernhard E.J., Gruber S.B., Muschel R.J. Direct evidence linking expression of matrix metalloproteinase 9 (92-kDa gelatinase/collagenase) to the metastatic phenotype in transformed rat embryo cells. Proc. Natl. Acad. Sci. USA. 91:1994;4293-4297.
5. Bernhard E., Hagner B., Wong C., Lubenski I., Muschel R. The effect of E1A transfection on MMP-9 expression and metastatic potential. Int. J. Cancer. 60:1995;718-724.
6. Hua J., Muschel R. Inhibition of matrix metalloproteinase 9 expression by a ribozyme blocks metastasis in a rat sarcoma model system. Cancer Res. 56:1996;5279-5284.
7. Himelstein B.P., Canete-Soler R., Bernhard E.J., Dilks D.W., Muschel R.J. Metalloproteinases in tumor progression: the contribution of MMP-9. Invasion Metastasis. 1(6):1995;246-258.
8. Himelstein B., Canete-Soler R., Bernhard E., Muschel R. Induction of fibroblast 92 kDa gelatinase/type IV collagenase expression by direct contact with metastatic tumor cells. J. Cell Sci. 107:1994;477-486.
9. Fini M., Bartlett J., Matsubara M.et al. The rabbit gene for 92-kDa matrix metalloproteinase. J. Biol. Chem. 269:1994;28620-28628.
10. Huhtala P., Chow L., Tryggvason K. Structure of the human type IV collagenase gene. J. Biol. Chem. 265:1990;11077-11082.
11. Masure S., Nys G., Fiten P., Van Damme J., Opdenakker G. Mouse gelatinase B: cDNA cloning, regulation of expression and glycosylation in WEHI-3 macrophages and gene organisation. Eur. J. Biochem. 218:1993;129-141.
12. Sato H., Kita M., Seiki M. v-Src activates the expression of 92-kDa type IV collagenase gene through the AP-1 site and the GT box homologous to retinoblastoma control elements. J. Biol. Chem. 268:1993;23460-23468.
13. Sato H., Seiki M. Regulatory mechanism of 92 kDa type IV collagenase gene expression which is associated with invasiveness of tumor cells. Oncogene. 8:1993;395-405.
14. Xia Y., Garcia G., Chen S., Wilson C., Feng L. Cloning of rat 92-kDa type IV collagenase and expression of an active recombinant catalytic domain. FEBS Lett. 382:1996;285-288.
15. Himelstein B., Lee E., Sato H., Seiki M., Muschel R. Transcriptional activation of the matrix metalloproteinase-9 gene in an H-ras and v-myc transformed rat embryo cell line. Oncogene. 14:1997;1995-1998.
16. Dachs G., Stratford I. The molecular response of mammalian cells to hypoxia and the potential for exploitation in cancer therapy. Br. J. Cancer. 74:1996;S126-S132.
17. Bunn H., Poyton R. Oxygen sensing and molecular adaptation to hypoxia. Physiol. Rev. 76:1996;839-885.
18. Wang G., Jiang B., Rue E., Semenza G. Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension. Proc. Natl. Acad. Sci. USA. 92:1995;5510-5514.
19. Dachs G., Patterson A., Firth J.et al. Targeting gene expression to hypoxic tumor cells. Nat. Med. 3:1997;515-520.
20. Mazure N., Chen E., Yeh P., Laderoute K., Giaccia A. Oncogenic transformation and hypoxia synergistically act to modulate vascular endothelial growth factor expression. Cancer Res. 56:1996;3436-3440.
21. Mukhopadhyay D., Tsiokas L., Zhou X.-M., Foster D., Brugge J., Sukhatme V. Hypoxic induction of human vascular endothelial growth factor expression through c-Src activation. Nature. 375:1995;577-581.
22. Rupec R., Baeuerle P. The genomic response of tumor cells to hypoxia and reoxygenation. Differential activation of transcription factors AP-1 and NF-kB. Eur. J. Biochem. 234:1995;632-640.
23. Koong A., Chen Y., Giaccia A. Hypoxia causes the activation of nuclear factor κB through the phosphorylation of I κ Ba on tyrosine residues. Cancer Res. 54:1994;1425-1430.
24. Koong A., Chen E., Mivechi N., Denko N., Stambrook P., Giaccia A. Hypoxic activation of nuclear factor-κB is mediated by a ras and raf signaling pathway and does not involve MAP kinase (ERK1 or ERK2). Cancer Res. 54:1994;5273-5279.
25. Bernhard E., Muschel R., Hughes E. Mr 92,000 gelatinase release correlates with the metastatic phenotype in transformed rat embryo cells. Cancer Res. 50:1990;3872-3877.
26. Koch C., Stobbe C., Baer K. Metabolism induced binding of 14C-misonidazole to hypoxic cells: kinetic dependence on oxygen concentration and misonidazole concentration. Int. J. Radiat. Oncol. Biol. Phys. 10:1984;1327-1337.
27. Muschel R., Bernhard E., Garza L., McKenna W., Koch C. Induction of apoptosis at different oxygen tensions: evidence that oxygen radicals do not mediate apoptotic signaling. Cancer Res. 55:1995;995-998.
28. Berger J., Hauber J., Hauber R., Geiger R., Cullen B. Secreted placental alkaline phosphatase: a powerful new quantitative indicator of gene expression in eukaryotic cells. Gene. 66:1988;1-10.
29. Houghton J., Cook R., Lutz P., Houghton P. Childhood rhabdomyosarcoma xenografts: responses to DNA-interacting agents and agents used in current clinical therapy. Eur. J. Cancer Clin. Oncol. 20:1984;955-960.
30. Barr F., Gallili N., Holick J., Biegel J., Rovera G., Emanuel B. Rearrangement of the PAX3 paired box gene in the paediatric solid tumor alveolar rhabdomyosarcoma. Nat. Genet. 3:1993;113-117.
31. Krtolica A., Ludlow J. Hypoxia arrests ovarian carcinoma cell cycle progression, but invasion is unaffected. Cancer Res. 1996:1996;1168-1173.
32. Denko N., Giaccia A., Stringer J., Stambrook P. The human Ha-ras oncogene induces genomic instability in murine fibroblasts within one cell-cycle. Proc. Natl. Acad. Sci. USA. 91:1994;5124-5128.